Control group:Placebo and chemoradiotherapy

2 trials

Sponsors

Hunan Cancer Hospital, Cancer Prevention and Treatment Center of Guigang People's Hospital

Conditions

nasopharyngeal carcinoma

Phase 4

Metformin for chemoradiotherapy prevention in advanced nasopharyngeal carcinoma patients: a double-blind, placebo-controlled, randomized clinical trial

Active, not recruitingChiCTR2000028905

Hunan Cancer Hospitalnasopharyngeal carcinoma

Start: 2020-03-01Updated: 2020-01-13

Lenalidomide for chemoradiotherapy prevention in advanced nasopharyngeal carcinoma patients: a randomized, double-blind, placebo-controlled trial

Active, not recruitingChiCTR2000035365

Cancer Prevention and Treatment Center of Guigang People's Hospitalnasopharyngeal carcinoma

Start: 2020-08-08Updated: 2020-08-10